BridgeBio Pharma Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BBIO Nasdaq 2834 https://bridgebio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for BridgeBio Pharma Inc

Elon Musk-Led Neuralink Seeks Human Trial Collaborators, Credit Suisse May Face Disciplinary Action, First Citizens Takes Over Silicon Valley Bank: Today's Top Stories - Mar 27th, 2023 5:00 pm
Rare Disease Player BridgeBio Pharma Draws Attention Of Big Pharma Companies, Gets Takeover Interest - Mar 27th, 2023 1:50 pm
BridgeBio Pharma (BBIO) Moves 9.7% Higher: Will This Strength Last? - Mar 27th, 2023 9:52 am
BridgeBio Pharma Announces First Lung Cancer Patient Dosed in Phase 1 Trial for SHP2 Inhibitor BBP-398 in Combination with Bristol Myers Squibb’s OPDIVO® (nivolumab) - Mar 23rd, 2023 11:30 am
BridgeBio Pharma (BBIO) Surges 77% YTD: Here's Why - Mar 22nd, 2023 5:13 pm
BridgeBio Pharma Shares Preliminary Findings on Novel Bioassay Measuring Glycosylated Alpha-dystroglycan (⍺DG) in Patients with Limb-girdle Muscular Dystrophy Type 2I (LGMD2I) - Mar 21st, 2023 11:30 am
BridgeBio Pharma to Present Preliminary Findings on its Novel Bioassay Measuring Glycosylated Alpha-dystroglycan (⍺DG) in Patients with Limb-girdle Muscular Dystrophy Type 2I (LGMD2I) - Mar 17th, 2023 11:30 am
Is BridgeBio Pharma (BBIO) Stock Outpacing Its Medical Peers This Year? - Mar 10th, 2023 2:40 pm
Biotech Stock Roundup: PTGX Gains on Study Data, BMRN Faces Setback & More - Mar 9th, 2023 4:14 pm
BridgeBio Pharma Announces Pricing of Public Offering of Common Stock - Mar 8th, 2023 12:00 pm
Company News for Mar 7, 2023 - Mar 7th, 2023 2:35 pm
BridgeBio Soars 52% And Breaks Out After Smashing Expectations In A Dwarfism Study - Mar 6th, 2023 9:56 pm
BridgeBio Pharma Announces Proposed Public Offering of Common Stock - Mar 6th, 2023 9:05 pm
These 2 Biotech Stocks Made Big Monday Moves - Mar 6th, 2023 7:32 pm
2 Biotech Stocks Options Traders Are Watching - Mar 6th, 2023 6:36 pm
BridgeBio's Dwarfism Candidate Shows Favorable Height Increase, Safety Profile - Mar 6th, 2023 5:55 pm
Why BridgeBio Pharma Stock Is Skyrocketing Today - Mar 6th, 2023 5:22 pm
BridgeBio Stock Surges on Positive Dwarfism Drug Data. It’s Bad News for BioMarin. - Mar 6th, 2023 3:38 pm
BioMarin’s stock falls after another company’s dwarfism drug moves into Phase 3 clinical trials - Mar 6th, 2023 1:26 pm
Midday movers: Norfolk Southern, Apple, Tesla and more - Mar 6th, 2023 1:20 pm